The preliminary results buoy hope that after decades of failure and frustration, vaccines against RSV may finally be getting close.
For most healthy people, RSV, or respiratory syncytial virus, is a cold-like nuisance. But for the very young, the elderly and people with certain health problems, it can be serious, even life-threatening. The virus can infect deep in the lungs, causing pneumonia, and in babies it can impede breathing by inflaming tiny airways.
“For a period of 20 years, even though science was advancing, nobody wanted to go near development of an RSV vaccine,” Schaffner said. In 2013, McLellan and virologist Barney Graham were working at the National Institutes of Health when they homed in on the correct shape and figured out how to freeze it in that form. That finding opened the way to today’s development of a variety of experimental RSV vaccine candidates.Several companies are creating RSV vaccines but Pfizer and rival GSK are furthest along. Both companies recently reported final-stage testing in older adults.
Brasil Últimas Notícias, Brasil Manchetes
Similar News:Você também pode ler notícias semelhantes a esta que coletamos de outras fontes de notícias.
Vaccinating pregnant women protects their newborns from RSV, new study suggestsNew research shows vaccinating pregnant women helped protect their newborns from the common but scary respiratory virus called RSV that fills hospitals with wheezing babies each fall.
Consulte Mais informação »
RSV, flu and COVID: With new brew of viruses, doctors warn of reinfections and triple infections'Those are the big three that we're really worried about this winter,' said a doctor in Long Beach. 'We wouldn't want to see any child with all three or more at the same time.'
Consulte Mais informação »
Pfizer's New Vaccine Candidate For RSV Comes Just in Time For Major Spike in Infection RatesThe US is seeing an unseasonably early spread of RSV. What to know about the respiratory virus that could impact your infant.
Consulte Mais informação »
Pfizer says study shows vaccinating pregnant women protects newborns from RSVThe preliminary results buoy hope that after decades of failure and frustration, vaccines against RSV may finally be getting close.
Consulte Mais informação »
Pfizer RSV vaccine given to pregnant mothers is effective at protecting newborns, company's data showsPfizer said it will submit an application to the Food and Drug Administration for the RSV vaccine's approval by the end of 2022.
Consulte Mais informação »
Pfizer says study shows vaccinating pregnant women protects newborns from RSVThe preliminary results buoy hope that after decades of failure and frustration, vaccines against RSV may finally be getting close.
Consulte Mais informação »